N'-((Benzo[d]isoxazol-3-ylmethyl)sulfonyl)-N,N-dimethylformimidamide

Catalog No. :
ACAEWN926
CAS No. :
1217201-89-2
Molecular Formula :
C11H13N3O3S
Molecular Weight :
267.31

IUPAC Name:N'-((benzo[d]isoxazol-3-ylmethyl)sulfonyl)-N,N-dimethylformimidamide

N'-((Benzo[d]isoxazol-3-ylmethyl)sulfonyl)-N,N-dimethylformimidamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN'-((Benzo[d]isoxazol-3-ylmethyl)sulfonyl)-N,N-dimethylformimidamide
IUPAC NameN'-((benzo[d]isoxazol-3-ylmethyl)sulfonyl)-N,N-dimethylformimidamide
Molecular FormulaC11H13N3O3S
Molecular Weight267.31
SMILESCN(C)C=NS(=O)(CC1=NOC2=CC=CC=C12)=O
InChI KeyIIGSDTSFCPJXKF-UHFFFAOYSA-N
SynonymZonisamide N,N-Dimethylformimidamide;(N')-Benzisox-3-ylMethylsulfonyl)-N,N-diMethylforMiMidaMide;N,N-DiMethyl ZonisaMide;N'-(1,2-benzoxazol-3-ylmethylsulfonyl)-N,N-dimethylmethanimidamide;Methanimidamide, N'-[(1,2-benzisoxazol-3-ylmethyl)sulfonyl]-N,N-dimethyl-;Zonisamide Related Compound C N,N-Dimethyl Formimidamide;(E)-N'-((benzo[d]isoxazol-3-ylmethyl)sulfonyl)-N,N- dimethylformimidamide;N'-((Benzo[d]isoxazol-3-ylmethyl)sulfonyl)-N,N-dimethylformimidamide
CAS No.1217201-89-2

Synthetic Route by SureRoute

1. ACAEWN926 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAEWN926 route product structure diagram
    ACAEWN9261217201-89-2
Inquiry

2. ACAEWN926 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACSKHF719 route compound structure diagram
    ACSKHF71968291-97-4 In Stock
  4. Then
  5. ACAEWN926 route product structure diagram
    ACAEWN9261217201-89-2
Inquiry

Comments (0)